Antimicrobial prophylaxis for percutaneous liver biopsy

role of percutaneous liver biopsy

Morbidity after percutaneous liver biopsy.

The safety of percutaneous liver biopsy with a 1.2 mm Menghini needle in infants aged one year or less was investigated. One hundred and eighty four procedures performed from 1975 to 1985 were reviewed. There were no deaths or major complications within 48 hours associated with the procedure. In five instances specific complications occurred: a drop in haemoglobin concentration (three), transie...

Role of Percutaneous Liver Biopsy

We read the interesting study by Szymczak et al. (1) regarding the safety and effectiveness of a blind per-cutaneous liver biopsy, where they concluded that the failure rate and the risk of complications are low if indications and contraindications are carefully considered. Moreover, these authors emphasize how important it is that biopsies are performed by skilled and experienced operators. Th...

Hemoperitoneum after percutaneous liver biopsy

Percutaneous liver biopsy (PLB) is an in or out-patient procedure diffused in most hospitals. A particularely elevate number of biopsies in our area depends on endemic infection by hepatitis B and C viruses. Nowadays it is a very safe procedure, and the actual risk of bleeding is estimated to range between 0.04 and 0.16% in nonmalignant disease 1. Major bleeding generally requires a prompt surg...

Drug-Eluting Biopsy Needle as a Novel Strategy for Antimicrobial Prophylaxis in Transrectal Prostate Biopsy

OBJECTIVES To preclinically evaluate drug-eluting biopsy needles (patent pending WO2016118026) as a new potential way of antimicrobial prophylaxis for transrectal prostate biopsy. METHODS Twenty steel biopsy needles have been coated with polyvinyl alcohol, ciprofloxacin, and amikacin. Modified biopsy needles have been randomly divided into 3 groups (1:2:1 ratio). Needles from group I were imm...